Melasma is a common skin condition characterised by dark, discoloured patches on the face and other sun-exposed areas. It is caused by excessive melanin production and can be triggered by hormonal changes, sun exposure, and genetic factors. While harmless, melasma can be distressing for those affected and may require various treatment approaches depending on the type and severity.
Last updated on : 22 Apr, 2026
Read time : 13 mins

Melasma is a skin condition that affects millions of people worldwide, causing dark patches or freckle-like spots to appear primarily on the face, though it may occasionally appear on other sun-exposed areas. It is often referred to as the "mask of pregnancy" due to its high prevalence among pregnant women, but it can affect anyone, regardless of age or gender. In this article, we will explore the causes, types, symptoms, and treatment options for melasma.
Melasma is a benign hyperpigmentation disorder characterised by the appearance of dark, discoloured patches on the skin, primarily on the face. It is caused by the excessive production of melanin, the skin pigment responsible for skin colour. Various factors, including hormonal fluctuations, sun exposure, and genetic predisposition, can trigger melasma. Understanding the nature of this condition is crucial for those seeking effective management and treatment options.
| Category | Details |
| Also Referred to as | Chloasma, "mask of pregnancy" |
| Commonly Occurs In | Women aged 20–40 years, especially those with darker skin tones |
| Affected Organ | Skin (face, sun-exposed areas) |
| Type | Epidermal, dermal, mixed |
| Common Signs | Brown, blue-grey patches, freckle-like spots, irregular borders, often symmetrical on the face |
| Consulting Specialist | Dermatologist |
| Treatment Procedures | Topical skin-lightening agents, chemical peels, laser/light therapies, microneedling (used cautiously and typically not first-line due to risk of post-inflammatory hyperpigmentation) |
| Managed By | Bleaching agents (hydroquinone); topical epidermal turnover enhancers such as retinoids (e.g., tretinoin, adapalene) (topical isotretinoin formulations are not routinely used or supported for melasma). Alpha- and beta-hydroxy acids (for example, glycolic acid, mandelic acid, and salicylic acid) may be used as adjuncts to improve epidermal turnover. Other agents that target melanin synthesis pathways may also be used. |
| Mimicking Condition | Freckles, age spots, sun spots, liver spots, and certain skin cancers (e.g., melanoma) |
Melasma can be categorised into three main types based on the level of increased melanin in the skin. These include:
Melasma can appear on various areas of the body, but it most commonly affects the face, particularly the cheeks, forehead, bridge of the nose, chin, and upper lip. It can also appear on other sun-exposed areas, such as the neck, arms, back, and forearms.
The most common symptoms of melasma include:
Melasma is a complex skin condition caused by various factors that lead to an increase in melanin production by overactive melanocytes in the skin. These include:
Several factors can increase the likelihood of developing melasma, including:
Melasma can affect anyone, but certain groups are at a higher risk, including:
While melasma is primarily a cosmetic concern, it can lead to several complications that may affect an individual's emotional and physical well-being. Some of the complications include:
Preventing melasma involves a combination of lifestyle changes and protective measures, especially for individuals at higher risk. These include:
Diagnosing melasma typically involves a combination of clinical evaluation and patient history. The diagnosis is generally made using:
A dermatologist will begin by examining the affected areas of the skin. They will look for the characteristic brown or grey-brown patches, often on sun-exposed areas like the face, neck, and forearms. The symmetry and pattern of the discolouration are also noted, as melasma typically presents bilaterally.
In some cases, a wood's lamp may be used. This special light helps determine the depth of the pigmentation—whether it is superficial (epidermal) or deeper (dermal) (AAD, 2022).
Hormonal factors can contribute to melasma. However, routine measurement of hormone levels such as follicle-stimulating hormone (FSH), luteinizing hormone (LH), and prolactin is not routinely recommended. Assessment of pregnancy status and thyroid function may be considered if clinically indicated. A detailed medical and medication history is often more useful in identifying hormone-related triggers.
Dermoscopy is a non-invasive imaging method that allows for an in-depth analysis of skin pigmentation. A specialised device called a dermatoscope magnifies the skin, enabling dermatologists to assess the extent and depth of melanin deposits. By capturing high-resolution images (when available), this technique aids in evaluating the severity of melasma and guiding management decisions.
Managing melasma involves a combination of topical treatments, advanced diagnostic techniques, and targeted therapies to reduce hyperpigmentation.
The first-line treatments include hydroquinone (typically 2–4% under dermatologic supervision), azelaic acid (20%), kojic acid, thiamidol, niacinamide, 0.05%–0.1% tretinoin, or adapalene as retinoid agents to enhance epidermal turnover and hydroquinone penetration. Chemical exfoliants such as glycolic or mandelic acid can be adjunctive. Therapeutic choices should be individualised to skin type and tolerability; oral isotretinoin is not used in the management of melasma (Gan et al., 2024).
Triple-combination topical therapy (TCC) typically contains hydroquinone (commonly 2–4%) with a topical retinoid (e.g., tretinoin 0.025–0.1%) and a low-potency topical corticosteroid (commonly fluocinolone acetonide 0.01% in commercial formulations such as Tri-Luma). Other corticosteroids (e.g., mometasone) are not usually recommended for long-term use because of higher atrophy risk; potent steroids should be used cautiously and only short-term under supervision (Gan et al., 2024). Combining agents (e.g., hydroquinone + tretinoin + a mild corticosteroid as TCC) often improves outcomes and tolerability. Antioxidants such as topical vitamin C (ascorbic acid) and vitamin E may be helpful adjuncts. Ingredients and formulations should be described accurately — allantoin may be used as a soothing excipient in formulations, but it is not a primary depigmenting agent.
Dermoscopy, a non-invasive imaging technique, helps evaluate melanin depth and track management progress. Diagnosis remains primarily clinical, supported by tools such as dermoscopy and Wood’s lamp examination.
By integrating these targeted therapies and evaluation methods, melasma can be effectively managed, supporting better skin health and a more even complexion.
If you are experiencing symptoms of melasma, such as patches of discolouration on the face, it is important to consult a dermatologist for proper evaluation and treatment. Persistent or worsening symptoms warrant medical attention, as a doctor can help determine the best treatment options. Additionally, if over-the-counter treatments prove ineffective, or the condition is impacting your quality of life. In that case, it is advisable to consult a dermatologist for more targeted and effective treatment strategies.
Safety note about procedures: According to AAD (2022), procedures such as chemical peels and lasers can produce variable results and may worsen pigmentation (post-inflammatory hyperpigmentation) if performed inappropriately, particularly in darker skin types (Fitzpatrick IV–VI). These procedures should be done by experienced clinicians and only after adequate topical control and sun-protection measures are in place.
...View more
...View more
Company
About UsHealth ArticleHealth StoriesHealth LibraryDiseases & Health ConditionsAyurvedaUnderstanding Generic MedicinesAll MedicinesAll BrandsNeed HelpFAQSecuritySavings CalculatorSubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.23.3
2026 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners

